Barclays 27th Annual Global Healthcare Conference March 11, 2025 1:30 PM ETCompany ParticipantsRose Loughlin - EVP of ...

As we near the five-year anniversary of the COVID-19 pandemic, it's a good time to revisit the drugmaker stock that was top ...

The pandemic's volatility affected all public companies, but some saw their business deeply transformed. Here's how three of ...

We recently published a list of 10 Best Growth Stocks to Invest in for the Next 10 Years. In this article, we are going to ...

A new review article highlights the transformative role of circular RNA (circRNA) in cancer, revealing its potential as both a key player in tumor biology and a promising avenue for future therapies.

Despite high R&D spending and cash burn, Moderna aims for breakeven by 2028, driven by new vaccine opportunities. Explore ...

A new review article highlights the transformative role of circular RNA (circRNA) in cancer, revealing its potential as both a key player in tumor ...

President Trump’s pick to lead the National Institutes of Health (NIH) faced questions from senators Wednesday on his plans for vaccine research, ideas for pushing down drug prices, and response ...

A new review article highlights the transformative role of circular RNA (circRNA) in cancer, revealing its potential as both ...

Is MRNA stock a sell? Investing.com -- Citi has expanded its biopharmaceutical research coverage, initiating coverage on seven small- and mid-cap (SMid ... between $1.5 billion and ...